These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

84 related items for PubMed ID: 1988093

  • 61. In vitro antitumor activity of 2'-deoxy-5-fluorouridine-monoclonal antibody conjugates.
    Goerlach A, Krauer KG, McKenzie IF, Pietersz GA.
    Bioconjug Chem; 1991; 2(2):96-101. PubMed ID: 1831049
    [Abstract] [Full Text] [Related]

  • 62. Monoclonal antibody administration. Current clinical pharmacokinetic status and future trends.
    Begent RH, Pedley RB.
    Clin Pharmacokinet; 1992 Aug; 23(2):85-9. PubMed ID: 1511531
    [No Abstract] [Full Text] [Related]

  • 63. Growth-promoting effect of oestriol in a lymphoma lacking oestrogen receptors.
    Kawatsu R, Ezaki T, Kotani M, Akagi M.
    Br J Cancer; 1989 Apr; 59(4):563-8. PubMed ID: 2713243
    [Abstract] [Full Text] [Related]

  • 64. In vivo 1H-NMR microimaging with respiratory triggering for monitoring adoptive immunotherapy of metastatic mouse lymphoma.
    Fichtner KP, Schirrmacher V, Griesbach A, Hull WE.
    Magn Reson Med; 1997 Sep; 38(3):440-55. PubMed ID: 9339446
    [Abstract] [Full Text] [Related]

  • 65. Involvement of the thymus by metastic neoplasms.
    Middleton G.
    Br J Cancer; 1966 Mar; 20(1):41-6. PubMed ID: 5936684
    [No Abstract] [Full Text] [Related]

  • 66. Preclinical investigation of the antitumour effects of anti-CD19-idarubicin immunoconjugates.
    Rowland AJ, Pietersz GA, McKenzie IF.
    Cancer Immunol Immunother; 1993 Aug; 37(3):195-202. PubMed ID: 7687521
    [Abstract] [Full Text] [Related]

  • 67. Antitumor activity of idarubicin-monoclonal antibody conjugates in a disseminated thymic lymphoma model.
    Smyth MJ, Bogdanovski M, McKenzie IF, Pietersz GA.
    Cancer Res; 1991 Jan 01; 51(1):310-7. PubMed ID: 1988093
    [Abstract] [Full Text] [Related]

  • 68. Immunochemotherapy of a murine thymoma with the use of idarubicin monoclonal antibody conjugates.
    Pietersz GA, Smyth MJ, McKenzie IF.
    Cancer Res; 1988 Feb 15; 48(4):926-31. PubMed ID: 3422182
    [Abstract] [Full Text] [Related]

  • 69. Tumour eradication with high-dose idarubicin-anti-Ly-2.1 with murine tumour necrosis factor-alpha in mice.
    Pietersz GA, Bogdanovski M, Li W.
    Immunol Cell Biol; 1997 Jun 15; 75(3):253-8. PubMed ID: 9243290
    [Abstract] [Full Text] [Related]

  • 70. Antitumor effect of 2'-deoxy-5-fluorouridine conjugates against a murine thymoma and colon carcinoma xenografts.
    Krauer KG, McKenzie IF, Pietersz GA.
    Cancer Res; 1992 Jan 01; 52(1):132-7. PubMed ID: 1530766
    [Abstract] [Full Text] [Related]

  • 71. Targeted cancer therapy: conferring specificity to cytotoxic drugs.
    Chari RV.
    Acc Chem Res; 2008 Jan 01; 41(1):98-107. PubMed ID: 17705444
    [Abstract] [Full Text] [Related]

  • 72. Antitumor activity of idarubicin-monoclonal antibody conjugates in a disseminated thymic lymphoma model.
    Smyth MJ, Bogdanovski M, McKenzie IF, Pietersz GA.
    Cancer Res; 1991 Jan 01; 51(1):310-7. PubMed ID: 1988093
    [Abstract] [Full Text] [Related]

  • 73. Immunochemotherapy of a murine thymoma with the use of idarubicin monoclonal antibody conjugates.
    Pietersz GA, Smyth MJ, McKenzie IF.
    Cancer Res; 1988 Feb 15; 48(4):926-31. PubMed ID: 3422182
    [Abstract] [Full Text] [Related]

  • 74. Tumour eradication with high-dose idarubicin-anti-Ly-2.1 with murine tumour necrosis factor-alpha in mice.
    Pietersz GA, Bogdanovski M, Li W.
    Immunol Cell Biol; 1997 Jun 15; 75(3):253-8. PubMed ID: 9243290
    [Abstract] [Full Text] [Related]

  • 75.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 76. Enhanced antitumour effects using a combination of two antibodies conjugated to different drugs.
    Rowland AJ, McKenzie IF, Pietersz GA.
    J Drug Target; 1994 Jun 15; 2(2):113-21. PubMed ID: 8069589
    [Abstract] [Full Text] [Related]

  • 77.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 78. Targeted cancer therapy: conferring specificity to cytotoxic drugs.
    Chari RV.
    Acc Chem Res; 2008 Jan 15; 41(1):98-107. PubMed ID: 17705444
    [Abstract] [Full Text] [Related]

  • 79. Site-directed tumor chemotherapy.
    Arnon R.
    Compr Ther; 1978 Apr 15; 4(4):68-73. PubMed ID: 348397
    [Abstract] [Full Text] [Related]

  • 80.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.